Modulation of inflammation by kininogen deficiency in a rat model of inflammatory arthritis

Arthritis and Rheumatism

Volumn 52, Issue 8, 2005, Pages 2549-2552

  Sainz, Irma M ^a   Isordia Salas, Irma ^a   Castaneda, Julian L ^a   Agelan, Alexis ^a   Liu, Bo ^b   DeLa Cadena, Raul A ^a   Pixley, Robin A ^a   Adam, Albert ^c   Sartor, R Balfour ^b   Colman, Robert W ^a,d  

^a TEMPLE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KININOGEN; PEPTIDOGLYCAN POLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ARTHRITIS; ARTICLE; BACTERIAL CELL WALL; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; INFLAMMATION; INFLAMMATORY DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOCOCCUS PYOGENES;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BODY WEIGHT; DRUG COMBINATIONS; FOOT; HINDLIMB; INJECTIONS, INTRAPERITONEAL; JOINTS; KALLIKREIN-KININ SYSTEM; KININOGEN, HIGH-MOLECULAR-WEIGHT; PEPTIDOGLYCAN; POLYSACCHARIDES; RATS; RATS, INBRED BN; RATS, INBRED LEW;

EID: 23644439968     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21202     Document Type: Article

References (16)

1. Anderle SK, Greenblatt JJ, Cromartie WJ, Clark R, Schwab JH. Modulation of the susceptibility of inbred and outbred rats to arthritis induced by cell walls of group A streptococci. Infect Immun 1979;25:484-90.
2. Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN. Contact activation pathway: inflammatory, fibrinolytic, anticoagulant, antiadhesive, and antiangiogenic activities. In: Colman RW, editor. Hemostasis and thrombosis, basic principles and clinical practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 103-21.
3. Toossi Z, Sedor JR, Mettler MA, Everson B, Young T, Ratnoff OD. Induction of expression of monocyte interleukin 1 by Hageman factor (factor XII). Proc Natl Acad Sci U S A 1992;89: 11969-72.
4. Joseph K, Tholanikunnel BG, Kaplan AP. Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII. Proc Natl Acad Sci U S A 2002;99:896-900.
5. Shariat-Madar Z, Mahdi F, Schmaier AH. Recombinant prolylcarboxypeptidase activates plasma prekallikrein. Blood 2004;103: 4554-61.
6. Gallin JI, Kaplan AP. Mononuclear cell chemotactic activity of kallikrein and plasminogen activator and its inhibition by C1 inhibitor and α2-macroglobulin. J Immunol 1974;113:1928-34.
7. Kaplan AP, Joseph K, Silverberg M. Pathways for bradykinin formation and inflammatory disease [review]. J Allergy Clin Immunol 2002;109:195-209.
8. Khan MM, Bradford HN, Isordia-Salas I, Espinola R, Colman RW. High molecular weight kininogen fragments stimulate the secretion of interleukin-1β through the urokinase-type plasminogen activator receptor (u-P-R) and CD11b/CD18 (Mac-1) in human blood mononuclear cells [abstract]. Blood 2004;104:36b.
9. Isordia-Salas I, Pixley RA, Li F, Sainz I, Sartor RB, Adam A, et al. Kininogen deficiency modulates chronic intestinal inflammation in genetically susceptible rats. Am J Physiol Gastrointest Liver Physiol 2002;283:G180-6.
10. Isordia-Salas I, Pixley RA, Parekh H, Kunapuli SP, Li F, Stadnicki A, et al. The mutation Ser511 Asn leads to N-glycosylation and increases the cleavage of high molecular weight kininogen in rats genetically susceptible to inflammation. Blood 2003;102:2835-42.
11. Mankin HJ, Dorfman H, Lippiello L, Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 1971;53:523-37.
12. Espinola RG, Uknis A, Sainz IM, Isordia-Salas I, Pixley R, DeLa Cadena R, et al. A monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritis. Am J Pathol 2004;165:969-76.
13. Keith JJ, Sainz IM, Isordia-Salas I, Pixley RA, Leathurby Y, Albert LM, et al. A monoclonal antibody against kininogen reduces inflammation in the HLA-B27 transgenic rat. Arthritis Res Ther 2005;7:R769-76.
14. Ueno A, Oh-ishi S. Roles for the kallikrein-kinin system in inflammatory exudation and pain: lessons from studies on kininogen-deficient rats [review]. J Pharmacol Sci 2003;93:1-20.
15. Hayashi I, Amano H, Yoshida S, Kamata K, Kamata M, Inukai M, et al. Suppressed angiogenesis in kininogen-deficiencies. Lab Invest 2002;82:871-80.
16. Parenti A, Morbidelli L, Ledda F, Granger HJ, Ziehe M. The bradykinin/B1 receptor promotes angiogenesis by up-regulation of endogenous FGF-2 in endothelium via the nitric oxide synthase pathway. FASEB J 2001;15:1487-9.